Spermatocele – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:35:09 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Spermatocele – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Sclerotherapy for Hydrocele and Spermatocele Using Lauromacrogol 400 and Ethanol in Adult Patients https://clinicaltrials.eu/trial/study-on-sclerotherapy-for-hydrocele-and-spermatocele-using-lauromacrogol-400-and-ethanol-in-adult-patients/ Wed, 29 Apr 2026 14:58:10 +0000 https://clinicaltrials.eu/trial/study-on-sclerotherapy-for-hydrocele-and-spermatocele-using-lauromacrogol-400-and-ethanol-in-adult-patients/ This clinical trial is focused on studying the treatment of two conditions: hydrocele and spermatocele. These are conditions where fluid accumulates in the scrotum, causing swelling. The study will use a treatment called Aetoxysclerol, which is a solution for injection, and it will be compared with a combination of Aetoxysclerol and ethanol, a type of alcohol. The purpose of the study is to compare the effectiveness of these treatments in reducing symptoms and the need for additional treatment.

Participants in the study will receive either Aetoxysclerol alone or in combination with ethanol. The study will also look at the level of pain experienced during treatment, with or without the use of local anesthesia, which is a type of medication used to numb a specific area of the body. The study will monitor symptoms and any need for retreatment over a period of three months after the initial treatment.

The trial will also assess any complications that may arise within 30 days of treatment and will continue to observe symptoms for up to 24 months. The study aims to provide valuable information on the best treatment approach for managing hydrocele and spermatocele, helping to improve patient care and outcomes in the future.

]]>